Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica A Konerman

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Clinics in Liver Disease|October 16, 2016
Interferon Treatment for Hepatitis BMonica A Konerman, Anna S Lok
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 28, 2014
Is it more cost-effective for patients with chronic hepatitis b to have a trial of interferon before considering Nucleos(t)ide analogue therapy?Monica A Konerman, Anna S Lok
JAMA|July 25, 2014
Diagnostic challenges of hepatitis CMonica A Konerman, Anna S Lok
ACG Case Reports Journal|December 24, 2016
Endoscopic Ultrasound as a Diagnostic Tool in a Case of Obscure HemobiliaMonica A Konerman, Zishu Zhang, Cyrus Piraka
Clinical and Translational Gastroenterology|September 23, 2016
Hepatitis C Treatment and Barriers to EradicationMonica A Konerman, Anna S F Lok
Journal of Hepatology|November 11, 2017
Pharmacotherapy for NASH: Current and emergingMonica A Konerman, Jacob C Jones, Stephen A Harrison
Journal of Hepatology|March 24, 2018
Corrigendum to "Pharmacotherapy for NASH: Current and emerging" [J Hepatol 68 (2017) 362-375]Monica A Konerman, Jacob C Jones, Stephen A Harrison
Therapeutic Advances in Gastroenterology|September 2, 2014
Randomized, controlled pilot study comparing large-volume paracentesis using wall suction and traditional glass vacuum bottle methodsMonica A Konerman, Jennifer Price, Dawn Torres, et al.
Digestive Diseases and Sciences|March 10, 2016
Primary Care Physician Perspectives on Hepatitis C Management in the Era of Direct-Acting Antiviral TherapyMary Thomson, Monica A Konerman, Hetal Choxi, et al.
Transplantation|March 16, 2017
Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes After Liver Transplantation: A Systematic ReviewMonica A Konerman, Danielle Fritze, Richard L Weinberg, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinics in Liver Disease|October 16, 2016
Interferon Treatment for Hepatitis BMonica A Konerman, Anna S Lok
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 28, 2014
Is it more cost-effective for patients with chronic hepatitis b to have a trial of interferon before considering Nucleos(t)ide analogue therapy?Monica A Konerman, Anna S Lok
JAMA|July 25, 2014
Diagnostic challenges of hepatitis CMonica A Konerman, Anna S Lok
ACG Case Reports Journal|December 24, 2016
Endoscopic Ultrasound as a Diagnostic Tool in a Case of Obscure HemobiliaMonica A Konerman, Zishu Zhang, Cyrus Piraka
Clinical and Translational Gastroenterology|September 23, 2016
Hepatitis C Treatment and Barriers to EradicationMonica A Konerman, Anna S F Lok
Journal of Hepatology|November 11, 2017
Pharmacotherapy for NASH: Current and emergingMonica A Konerman, Jacob C Jones, Stephen A Harrison
Journal of Hepatology|March 24, 2018
Corrigendum to "Pharmacotherapy for NASH: Current and emerging" [J Hepatol 68 (2017) 362-375]Monica A Konerman, Jacob C Jones, Stephen A Harrison
Therapeutic Advances in Gastroenterology|September 2, 2014
Randomized, controlled pilot study comparing large-volume paracentesis using wall suction and traditional glass vacuum bottle methodsMonica A Konerman, Jennifer Price, Dawn Torres, et al.
Digestive Diseases and Sciences|March 10, 2016
Primary Care Physician Perspectives on Hepatitis C Management in the Era of Direct-Acting Antiviral TherapyMary Thomson, Monica A Konerman, Hetal Choxi, et al.
Transplantation|March 16, 2017
Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes After Liver Transplantation: A Systematic ReviewMonica A Konerman, Danielle Fritze, Richard L Weinberg, et al.
Pageof 3